Abrdn PLC Teva Pharmaceutical Industries LTD Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Abrdn PLC holds 593,193 shares of TEVA stock, worth $10.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

593,193

Previous 680,705 12.86%

Holding current value

$10.1 Million

Previous $11.1 Million 3.36%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$15.81 - $18.96 $1.38 Million - $1.66 Million	-87,512 Reduced 12.86%	593,193 $10.7 Million
Q2 2024 Aug 09, 2024	BUY	$12.78 - $17.4 $1.05 Million - $1.43 Million	81,998 Added 13.7%	680,705 $11.1 Million
Q1 2024 May 08, 2024	BUY	$10.67 - $14.43 $925,313 - $1.25 Million	86,721 Added 16.94%	598,707 $8.45 Million
Q4 2023 Jan 31, 2024	BUY	$8.12 - $10.63 $3.65 Million - $4.77 Million	449,053 Added 713.54%	511,986 $5.35 Million
Q3 2023 Nov 06, 2023	SELL	$7.48 - $10.7 $6,821 - $9,758	-912 Reduced 1.43%	62,933 $641,000
Q2 2023 Jun 20, 2024	SELL	$7.2 - $9.47 $26,244 - $34,518	-3,645 Reduced 5.4%	63,845 $480,000
Q2 2023 Aug 04, 2023	SELL	$7.2 - $9.47 $26,244 - $34,518	-3,645 Reduced 5.4%	63,845 $480,000
Q1 2023 Jun 20, 2024	BUY	$8.36 - $11.37 $68,460 - $93,108	8,189 Added 13.81%	67,490 $597,000
Q1 2023 Apr 28, 2023	BUY	$8.36 - $11.37 $68,460 - $93,108	8,189 Added 13.81%	67,490 $597,000
Q4 2022 Jun 20, 2024	SELL	$7.95 - $9.48 $4.29 Million - $5.11 Million	-539,406 Reduced 90.1%	59,301 $540,000
Q4 2022 Feb 09, 2023	SELL	$7.95 - $9.48 $49,329 - $58,823	-6,205 Reduced 9.47%	59,301 $540,000
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $133,934 - $233,311	-19,524 Reduced 22.96%	65,506 $529,000
Q2 2022 Aug 05, 2022	SELL	$7.38 - $10.4 $141,939 - $200,023	-19,233 Reduced 18.45%	85,030 $676,000
Q1 2022 May 04, 2022	BUY	$7.33 - $9.39 $120,893 - $154,869	16,493 Added 18.79%	104,263 $978,000
Q4 2021 Feb 08, 2022	SELL	$7.9 - $10.19 $91,798 - $118,407	-11,620 Reduced 11.69%	87,770 $703,000
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $77,213 - $93,798	9,214 Added 10.22%	99,390 $991,000
Q2 2021 Aug 10, 2021	BUY	$9.9 - $11.56 $63,657 - $74,330	6,430 Added 7.68%	90,176 $893,000
Q1 2021 May 06, 2021	SELL	$10.34 - $12.81 $97,537 - $120,836	-9,433 Reduced 10.12%	83,746 $967,000
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $592,144 - $759,264	-68,774 Reduced 42.47%	93,179 $900,000
Q3 2020 Oct 21, 2020	SELL	$8.57 - $12.69 $58,395 - $86,469	-6,814 Reduced 4.04%	161,953 $1.46 Million
Q2 2020 Aug 10, 2020	BUY	$8.12 - $13.12 $129,278 - $208,883	15,921 Added 10.42%	168,767 $2.08 Million
Q1 2020 May 13, 2020	SELL	$6.69 - $13.45 $119,490 - $240,230	-17,861 Reduced 10.46%	152,846 $1.37 Million
Q4 2019 Feb 18, 2020	SELL	$6.53 - $10.72 $620,859 - $1.02 Million	-95,078 Reduced 35.77%	170,707 $1.67 Million
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $260,611 - $406,147	-42,307 Reduced 13.73%	265,785 $1.83 Million
Q2 2019 Aug 13, 2019	BUY	$8.12 - $15.72 $518,055 - $1 Million	63,800 Added 26.12%	308,092 $2.84 Million
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $3.11 Million - $3.99 Million	199,300 Added 442.97%	244,292 $3.83 Million
Q4 2018 Feb 12, 2019	SELL	$14.59 - $23.84 $443,536 - $724,736	-30,400 Reduced 40.32%	44,992 $704,000
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $132,509 - $161,389	6,292 Added 9.11%	75,392 $1.62 Million
Q2 2018 Aug 09, 2018	SELL	$16.77 - $24.71 $233,103 - $343,469	-13,900 Reduced 16.75%	69,100 $1.68 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $1.28 Million - $2.67 Million	83,000	83,000 $1.46 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account